Hypogonadism
📧 Sign up to get email alerts when something new happens for Hypogonadism.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2020-06-23EMA Withdrawn: Fertavid (follitropin beta) — Merck Sharp & Dohme B.V.
Fertavid (follitropin beta) has been withdrawn from EMA status by Merck Sharp & Dohme B.V. with no remaining active medicinal products.
-
CLINICAL_TRIALS withdrawal · 2019-11-21Clinical Trial Update: Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction [Phase 2, Phase 3]
A clinical trial evaluating testosterone replacement to improve exercise capacity in hypogonadal men after acute myocardial infarction has b…
-
CLINICAL_TRIALS withdrawal · 2018-03-13Clinical Trial Update: Influence of Administration Route of Testosterone on Male Fertility [Phase 1]
A Phase 1 clinical trial evaluating whether the route of testosterone administration affects male fertility has been withdrawn.
-
EMA withdrawal · 2018-01-26EMA Refused: EnCyzix (enclomifene citrate) — Renable Pharma Limited
The EMA refused marketing authorization for EnCyzix (enclomifene citrate) by Renable Pharma Limited for the therapeutic area of hypogonadism…
-
CLINICAL_TRIALS withdrawal · 2017-08-24Clinical Trial Update: Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome
A clinical trial examining sexual dysfunction and low testosterone in patients with obstructive sleep apnea was withdrawn from the registry.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-07-19Clinical Trial Update: Testosterone Therapy in Heart Failure [NA]
A clinical trial evaluating testosterone therapy for heart failure has been withdrawn. No results are reported.
-
CLINICAL_TRIALS withdrawal · 2017-01-19Clinical Trial Update: Androgen Regulation of Priapism in Sickle Cell Disease [EARLY_Phase 1]
This document announces the withdrawal of an early-phase trial investigating androgen regulation of priapism in sickle cell disease.
-
CLINICAL_TRIALS withdrawal · 2015-08-10Clinical Trial Update: Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes [Phase 4]
A Phase 4 trial investigating testosterone gel replacement for fat mass in men with hypogonadism and diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-31Clinical Trial Update: Testosterone and Pain Sensitivity [Phase 4]
A Phase 4 clinical trial evaluating the relationship between testosterone and pain sensitivity, conducted by Johns Hopkins University, has b…
-
CLINICAL_TRIALS withdrawal · 2015-02-13Clinical Trial Update: Does Testosterone Improve Function in Hypogonadal Older Men [Phase 4]
Phase 4 clinical trial evaluating whether testosterone improves function in older men with hypogonadism has been withdrawn. The update notes…
-
CLINICAL_TRIALS withdrawal · 2014-06-02Clinical Trial Update: An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men [Phase 3]
Phase 3 trial evaluating ABT-SLV176 for the treatment of hypogonadism/testosterone deficiency has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-11-27Clinical Trial Update: Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks [Phase 4]
A Phase 4 clinical trial comparing Nebido to placebo for late-onset hypogonadism in elderly men has been withdrawn.